These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24728736)

  • 1. Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review.
    Bargiacchi O; Rossati A; Car P; Brustia D; Brondolo R; Rosa F; Garavelli PL; De Rosa FG
    Infection; 2014 Oct; 42(5):801-9. PubMed ID: 24728736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review.
    Khawcharoenporn T; Apisarnthanarak A; Mundy LM
    Clin Microbiol Infect; 2010 Jul; 16(7):888-94. PubMed ID: 19686281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug-resistant Gram-negative infections: the use of colistin.
    Michalopoulos AS; Karatza DC
    Expert Rev Anti Infect Ther; 2010 Sep; 8(9):1009-17. PubMed ID: 20818945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration alone in intracranial infections.
    Ni M; Zhao L; Zhang WJ; Ma JW; Zhang GY; Cui DM; Wang K; Fei YB; Gao L; Shen FM
    Int J Antimicrob Agents; 2021 Mar; 57(3):106281. PubMed ID: 33465459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraventricular treatment of paediatric meningitis due to extensively drug-resistant Gram-negative bacteria: two case reports and review of the literature.
    Deniz M; Tapısız A; Börcek AÖ; Tezer H
    J Chemother; 2021 Nov; 33(7):509-516. PubMed ID: 34013828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal or intraventricular colistin: a review.
    Bargiacchi O; De Rosa FG
    Infez Med; 2016; 24(1):3-11. PubMed ID: 27031890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.
    Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S
    J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-surgical meningitis due to multiresistant Acinetobacter baumannii. Effective treatment with intravenous and/or intraventricular colistin and therapeutic dilemmas.
    Paramythiotou E; Karakitsos D; Aggelopoulou H; Sioutos P; Samonis G; Karabinis A
    Med Mal Infect; 2007 Feb; 37(2):124-5. PubMed ID: 17270377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections.
    Huang J; Tang YQ; Sun JY
    Scand J Infect Dis; 2010 Apr; 42(4):260-5. PubMed ID: 20085424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colistin administration to pediatric and neonatal patients.
    Iosifidis E; Antachopoulos C; Ioannidou M; Mitroudi M; Sdougka M; Drossou-Agakidou V; Tsivitanidou M; Roilides E
    Eur J Pediatr; 2010 Jul; 169(7):867-74. PubMed ID: 20119725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Colistin for the Treatment of Multidrug-resistant Gram-negative Infections in Neonates and Infants: A Review of the Literature.
    Nakwan N; Chokephaibulkit K; Imberti R
    Pediatr Infect Dis J; 2019 Nov; 38(11):1107-1112. PubMed ID: 31469781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraventricular or intrathecal colistin for the treatment of central nervous system infections caused by multidrug-resistant Gram-negative bacteria.
    Imberti R; Iotti GA; Regazzi M
    Expert Rev Anti Infect Ther; 2014 Apr; 12(4):471-8. PubMed ID: 24597575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections.
    Cheng CY; Sheng WH; Wang JT; Chen YC; Chang SC
    Int J Antimicrob Agents; 2010 Mar; 35(3):297-300. PubMed ID: 20045293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenteral colistin for the treatment of severe infections: a single center experience.
    Tanita MT; Carrilho CM; Garcia JP; Festti J; Cardoso LT; Grion CM
    Rev Bras Ter Intensiva; 2013; 25(4):297-305. PubMed ID: 24553511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal use of colistin.
    Vasen W; Desmery P; Ilutovich S; Di Martino A
    J Clin Microbiol; 2000 Sep; 38(9):3523. PubMed ID: 11203334
    [No Abstract]   [Full Text] [Related]  

  • 17. Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review.
    Ng J; Gosbell IB; Kelly JA; Boyle MJ; Ferguson JK
    J Antimicrob Chemother; 2006 Nov; 58(5):1078-81. PubMed ID: 16916866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colistin therapy for multidrug-resistant Gram-negative infection: clinical outcome and risk factors.
    Jun YH; Jeun SJ; Kang SH; Choi HJ
    Infection; 2013 Dec; 41(6):1195-8. PubMed ID: 24037723
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration of colistin methanesulfonate.
    Imberti R; Cusato M; Accetta G; Marinò V; Procaccio F; Del Gaudio A; Iotti GA; Regazzi M
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4416-21. PubMed ID: 22687507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyxins for CNS infections: Pharmacology and neurotoxicity.
    Velkov T; Dai C; Ciccotosto GD; Cappai R; Hoyer D; Li J
    Pharmacol Ther; 2018 Jan; 181():85-90. PubMed ID: 28750947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.